Abstract
Norepinephrine (NE) is produced primarily by neurons in the locus coeruleus (LC). Retrograde and ultrastructural examinations reveal that the core of the LC and its surrounding region receives afferent projections from several brain areas which provide multiple neurochemical inputs to the LC with changes in LC neuronal firing, making it a highly coordinated event. Although NE and mediated signaling systems have been studied in relation to suicide and psychiatric disorders that increase the risk of suicide including depression, less is known about the corresponding changes in molecular network within LC. In this study, we examined miRNA networks in the LC of depressed suicide completers and healthy controls. Expression array revealed differential regulation of 13 miRNAs. Interaction between altered miRNAs and target genes showed dense interconnected molecular network. Functional clustering of predicated target genes yielded stress induced disorders that collectively showed the complex nature of suicidal behavior. In addition, 25 miRNAs were pairwise correlated specifically in the depressed suicide group, but not in the control group. Altogether, our study revealed for the first time the involvement of LC based dysregulated miRNA network in disrupting cellular pathways associated with suicidal behavior.
Similar content being viewed by others
Introduction
Major depressive disorder (MDD) is one of the most debilitating mental disorders world-wide which can lead to significant morbidity and mortality1, 2. Although suicide is one of the most devastating consequences of major depression, the precise molecular mechanisms associated with suicidal behavior are yet to be clearly understood. Recent advancements in understanding the neurobiological complexities associated with suicidal behavior have undeniably accepted that aberrant information processing in pathways of participating neural circuits in susceptible brain areas may play a critical role in the pathogenesis of suicide3. Identification of epigenetic modifiers as potential regulators of gene function has gained increasing acceptance in explaining the inadvertent changes in cellular network as a consequence of dysregulated gene expression profile orchestrated by environmental stimuli4, 5. MicroRNAs (miRNAs) are one of the most important epigenetic modifiers that belong to non-coding RNA family with a precise epigenetic role to modulate the coding potential of transcribed mRNA pool based on characteristic sequence complementarity6. In humans so far, more than 2500 mature miRNAs have been annotated7 which can act as potential regulatory hub to control a wide array of complex gene network either through direct association or by indirect intermediates8. Despite the restricted size (~22 nucleotides) and limited potential to go through exon splicing for generating more structural variations, this small form factor exhibits a functional diversity in targeting diverse range of RNA molecules spanning from protein coding (mRNA) to long non-coding RNAs (lncRNA)9, 10. Since gene expression regulation by miRNAs can occur in a coordinated and cohesive fashion, miRNAs can regulate entire genetic circuitries and thereby play a critical role in maintaining biological homeostasis11, 12. Thus, any perturbations in the expression of miRNAs may result in the imbalance of homeostasis, which are often reflected as adaptive changes in the regulatory networks that can distinguish normal vs disease states. In this regard, in preclinical model of stress-induced behavioral depression, we have shown that in the prefrontal cortex not only a set of altered miRNAs could transduce wide-spread changes in underlying gene regulatory network implicated in neural plasticity and neural transmission, but they were also involved in causing phenotypic changes associated with depression13. Such coordinated changes in miRNA network were also found in the prefrontal cortex of depressed suicide individuals14.
As the origin point of noradrenergic neurons, locus coeruleus (LC) is one of the critical brain areas that is known to be involved in behaviors including attention and memory during cognitive tasks and stress response15. Pre-clinical studies show profound changes in LC related activities under stressful conditions due to lack of functional integration with hypothalamic-pituitary-adrenal (HPA) axis16, 17. In addition, aberrant responses of glutamate and gamma-aminobutyric acid (GABA) that provide direct input to LC, can elicit activity-dependent neuronal responses towards stressful stimuli18. The direct role of LC in depression and suicidal behavior comes from studies which demonstrate that supersensitive presynaptic α-2 adrenergic receptors can lead to reduced NE or serotonin, the neurotransmitters most implicated in depression and suicidal behavior19, 20. Altogether, these studies suggest that modulations in neurobiological functions associated with LC can cause serious consequences of discordant neurochemical output that can result in increased vulnerability to suicidal behavior19, 21,22,23.
To further understand the role of LC in suicidal behavior at the molecular level, we examined miRNA expression, miRNA regulatory network, and regulated gene expression in this brain area of depressed individuals who committed suicide. Our study provides empirical evidence that miRNAs are capable of altering potential gene regulatory networks and can yield functional clustering of predicated target genes associated with anxiety, hyperactive behavior, and stress-related disorders, which collectively show the complex nature of suicidal behavior. Furthermore, formation of specific coordinated regulatory network with a non-overlap** set of miRNAs identified in depressed-suicide subjects as compared to healthy group may be critical in induction of suicidal behavior.
Results
Subjects
The demographic characteristics of healthy non-psychiatric controls and suicide subjects are provided in Table 1. There were no significant differences in PMI (t = 1.36, df = 18, p = 0.19), brain pH (t = 0.46, df = 18, p = 0.65) or RIN24 (t = 0.81, df = 18, p = 0.43) between suicide subjects and healthy controls. Age was slightly, but significantly, higher in the control group compared with the suicide group (t = 3.37, df = 18, p = 0.003). There were 2 females and 9 males in control group and 3 females and 6 males in the suicide group.
Transcriptome-wide changes in miRNAs in LC of suicide subjects
The TLDA based miRNA profiler is comprised of two plates: A and B. As detailed in the methods section, each plate assays 377 miRNAs excluding 6 small RNA related genes incorporated in each plate as normalizer and a plant-specific ath-miR-159a as negative control. Initial sorting of miRNA genes was performed based on their Ct values. Genes showing Ct ≤ 35 were excluded from the analysis. Based on the median normalized ΔCT values, a hierarchical clustering of miRNAs was conducted across control and suicide groups following complete linkage and Euclidian distance method and is presented as a Heat Map (Fig. 1). When tested individually, a total of 13 miRNAs achieved statistical significance at p = 0.05 or better (Table 2). Perturbation analysis (SAM, Stanford University), which takes testing of multiple miRNAs into account, identified 13 of these miRNAs as significant at a very stringent false discovery rate of 1.52%. Of these, 8 miRNA belonged to plate A (miR-17-5p, miR-20b-5p, miR-106a-5p, miR-330-3p, miR-409-5p, miR-541-3p, miR-582-5p, miR-890), whereas 5 miRNAs were part of plate B (let-7g-3p, miR-99b-3p, miR-550-5p, miR-1179, miR-1197) (Table 2). Except miR-409-5p in plate A and let-7g-3p and miR-1197 in plate B, all the miRNAs were upregulated. Among upregulated miRNAs, miR-541-3p from plate A was the top ranking miRNA based on its maximum level of expression in the suicide group (fold change = 1.52). On the other hand, miR-550-5p from plate B had the highest expression upregulation (fold change = 1.57) in the suicide group. Among 3 downregulated miRNAs from plates A and B, miR-1197 showed the most change (fold change = 0.48), which was also the most significantly altered miRNA in the suicide group (p = 0.008) (Table 2). All the significantly altered miRNAs in MDD-suicide group are represented as scattered plots in Supplementary Fig. 1. When correlated with confounding variables, we did not find any significant effects of age, PMI or brain pH on the expression of above mentioned altered miRNAs except miR-890 which correlated positively with age in the control group (Supplementary Table 2a). No significant effect of gender was observed on any of the miRNAs except miR-1179, whose expression was significantly higher in the female group (Supplementary Fig. 2)
Clustering of significantly dysregulated miRNAs based on their localization on chromosomes in LC of suicide subjects
The genomic localization of each significantly altered miRNA is shown in Table 2, which was curated following the recent release of miRbase (v.21) database (Manchester, UK). Table 2 also indicates the orientation of transcriptional unit for each individual miRNA which is denoted as either sense or antisense strand of duplex genomic DNA. miRNAs miR-20b-5p, miR-106a-5p and miR-890, which were found to be localized on chromosome X, showed a similar magnitude of increase (~1.25 fold) in LC of suicide subjects. Interestingly, the transcriptional unit for these 3 miRNAs was found to be localized on antisense strand. Apart from clustering on chromosome X, two more clustering groups were identified - one on chromosome 19 and another on chromosome 14. On chromosome 19, two miRNAs (miR-330-3p and miR-99b-3p) had their transcriptional units in opposite direction but they exhibited transcriptional upregulation with the similar fold change (~1.4 fold). On the other hand, three miRNAs (miR-409-5p, miR-541-3p and miR-1197) were located on chromosome 14 with the same directionality of transcription from sense strand. Of these, two miRNAs (miR-409-5p and miR-1197) showed changes in the same direction. These results suggest a coordinated regulation of miRNAs located on the same chromosome.
Functional clustering of differentially regulated miRNAs and their co-expression analysis in LC of suicide subjects following in silico approaches
As part of integrated miRNA-gene network study, relevance of the differentially regulated miRNAs was contemplated based on their target gene functionality. The computational selection of target genes (Supplementary Table 3) to interpret their global association with 13 differentially expressed miRNAs was performed using the algorithms of three different in silico tools: TargetScan, Ingenuity Expert Finding, and miRecords. The respective algorithms select target genes based on either prediction score which is determined by high to moderate confidence level of 3′UTR complementarity or experimentally validated records. Furthermore, functional map** of these selected target genes help in creating an integrated gene network (Fig. 2a) which elaborates the regulatory role of these differentially expressed miRNAs on target gene expression and associated cellular pathways.
Figure 3a displays network visualization for the core set of 25 miRNAs that were found to be pairwise correlated specifically with the suicide group, but not with the control group. Figure 3b reveals a set of 30 miRNAs, which were pairwise correlated specifically with the control group, but not with the suicide group. Interestingly, the miRNA co-expression network in the control group was very extensive where each miRNA was interconnected with 5–12 miRNAs within the network. On the other hand, in the suicide group, this network was not as dense and except miR-210, all the miRNAs correlated only with 3–4 other miRNAs within the network.
Analysis of gene regulatory networks associated with altered miRNAs
Since miRNAs are primarily known for their role in causing repressive effects on target gene expression via direct interaction, a possible downstream effect on a set of target genes is expected that may cause an overall dysfunctional status of associated cellular pathways. In this regard, an attempt was made to closely identify the gene networks associated with the subset of miRNAs which were found to be significantly upregulated in the suicide group (Fig. 2b). Closer attention was paid to construct the network based on genes which have previously been validated as target of those miRNAs. Identification of NTRK3, VEGFA, E2Fs, MMP2 as regulated candidate genes indicates the authenticity of this functional miRNA regulatory network.
As an additional measure to strengthen the gene regulatory network data and to have deeper insight on target gene regulation and their related functions, top three miRNAs (miR-541-3p, miR-550-5p and miR-1179) were chosen from upregulated miRNA list and an integrated target gene regulatory network (Fig. 4) was built based on the TargetScan-derived predicted target genes. The selection was based on the magnitude of upregulated expression in the suicide group (≥1.5 cutoff in relative fold change). Notably, each miRNA was found to create its own individual network with putative targets along with overlap** networks with the other two miRNAs where a number of genes were identified as shared targets receiving bimodal regulatory effect. Identification of critical genes (GRIA4, GRIN1, CAMKK, NGFR, NTRK2, SLC2A3, SLC6A8, SUV39H, METTL6, SLC12A5 and GSK3B) from this network for their well-documented role in neuropsychiatry and related epigenetics further indicates their anticipatory involvement in suicide pathology under the current study.
As part of the 10 upregulated miRNAs in the suicide group, a Heat Map was prepared based on the gene ontology of predicted target genes (Fig. 5a). A functional enrichment of genes was seen for TRK receptor signaling pathway and synaptic transmission as targets of miR-582-5p which ranked fourth in the list of 10 up regulated miRNAs. Target enrichment for the same TRK pathway and synaptic transmission was also observed for the other two top ranking miRNAs, e.g., miR-541-3p and miR-1179.
Abnormal cellular physiology is known to be the result of dysfunctional cellular pathways. Under the current study, similar observation was made in suicide subjects when putative target genes were mapped in various cellular pathways as part of the dysregulated miRNAs (Fig. 5b). Kyoto Encyclopedia of Genes and Genomes (KEGG) based pathway analysis25,26,27 demonstrated the possible involvement of 10 upregulated miRNAs and their canonical target genes (e.g. GABAA, GABAB, GABAC, VGCC, GAD, VGAT, GIRK2, PKC, CREB, CAMKII, PKA, GSK-3 and AKT) in impairing GABAergic and dopaminergic neurotransmission (Fig. 6a and b). Closer examination of the participating genes suggests functional enrichment of 50 genes as down regulated targets of 5 upregulated miRNAs in LC of suicide subjects with possible hindrance in GABAergic synaptic function (Supplementary Table 4). On the other hand, 31 target genes were identified as part of the upregulated miRNA network with compromised functional involvement in dopaminergic synapses (Supplementary Table 4). The putative target genes of 3 downregulated miRNAs in LC of suicide subjects and their possible functional map** in participating cellular pathways identified the involvement of glutamatergic synapse (Fig. 6c). Total 26 genes (Supplementary Table 5) were found to be part of this affected neurotransmitter pathway as being target of miR-409-5p and let-7g-3p; a majority of them were known to be linked with neural plasticity (GRIA3, GRIK3, GRIA4, GRIN2B) and glutamate signaling including feedback inhibition of glutamate release (SLC38A2, SLC1A2, GRM4, GRM7, PRKACB).
As observed from miRNA-target gene relationship, a set of predicted genes with strong neuropsychiatric background was found to be the target of more than one miRNA. Notably, GRIA3 (miR-330-3p, miR-1179), CREB1 (miR-17-5, miR-582-5p), ELF1 (miR-330-3p, miR-582-5p), CHRM2 (miR-1197, miR-17-5p, miR-541-3p), GRIK3 (miR-1197, miR-541-3p), NTRK2 (miR-1197, miR-541-3p), NTRK3 (miR-17-5p, miR-541-3p), EGF (miR-890, miR-330-3p), CREM (miR-1197, miR-330-3p, miR-582-5p) and GRM5 (miR-330-3p, miR-582-5p) showed the presence of canonical sites at their 3′ UTR with seed matches for more than one miRNA from the list of differentially expressed miRNAs.
Further attention was paid to create additional gene regulatory network based on the predicted targets of differentially altered miRNAs in the suicide group (Fig. 7). This time the integrated gene network was constructed with an emphasis to link their functional association with a few mental disabilities earlier found to be of high-risk factor for suicide. As can be seen in Fig. 7, an overlap** pattern of target gene regulation was prominent, which could be a combination of pathophysiological footprint of associated neuropsychiatric disorders as mapped on the network. The nodes in this network were represented as the genes with characteristic shapes that denote their function and the disorders were drawn as the hub in the network. Connections between hubs and nodes as well as between nodes are presented with broken line.
To further understand the relative involvement of identified target genes in disease physiology, functional clustering was considered, which resulted in identification of psychopathologies broadly related to mood disorders. Maximum gene set enrichment belonged to depressive disorder (64%), followed by anxiety (27%) and bipolar (9%) disorders (Supplementary Fig. 3a). In addition, ingenuity pathway based in silico analysis further dissected out anxiety related disorders based on its knowledgebase and retrieved a gene set enrichment for hyperactivity related disabilities (22%) as well as post-traumatic disorder (78%) (Supplementary Fig. 3b).
Besides disease related pathways, abnormalities in cellular pathways were also assessed based on the altered gene regulatory functions attributed by the targeting miRNAs. Following Fisher Exact Test with a p value threshold set at 0.05, the canonical pathway analysis module of IPA identified a list of pathways with relevance to neuropsychiatric disorders (Fig. 8a) such as protein kinase A signaling, phospholipase C signaling, glucocorticoid signaling, ERK/MAPK signaling, neurotrophin signaling, corticotropin releasing signaling, GABAergic signaling and glutamatergic signaling; all of them are known for their role in depression and suicidal behavior.
Expression analysis of protein coding target genes of altered miRNAs in LC of suicide subjects
To unravel the functional importance of significantly altered miRNAs in the LC of suicide subjects, a set of predicted target genes were screened and short listed based on their relevance in depression and suicide (RELN, GSK-3β, MAOA, CHRM1, PLCB1 and GRIK1). Relative quantification of these selected genes exhibited a common trend of expression down regulation (Fig. 8b) in the LC of suicide subjects compared with matched healthy controls except GRIK1 gene. Almost 50% expression attenuation was seen for RELN gene (Fig. 8b) which was found to be statistically significant (p = 0.03). Likewise, GSK-3β exhibited a similar pattern of downregulation at transcript level (~30%) with very high statistical significance (p = 0.009) (Fig. 8b). Reduced level was also found for MAOA gene, which showed a ~30% reduction in transcript level with a strong statistical significance (p = 0.03) across the analyzed samples (Fig. 8b). Interestingly, no significant change was identified in expression status of CHRM1 and PLCB1 genes; however, a relatively high level of expression downregulation (~56%) was observed for CHRM1 in suicide group (Fig. 8b). On the other hand, ~80% expression upregulation was noted for GRIK1 gene with a strong significance level (p = 0.04). The changes in expression of these altered genes were not associated with age, PMI or brain pH except MAO and PLCB1 genes. MAOA was positively correlated with PMI whereas PLCB1 showed significant correlation with pH (Supplementary Table 2b). Gender did not show any significant effect on RELN, GSK-3β, MAOA expression except CHRM1, PLCB1 and GRIK1 where CHRM1 and PLCB1 were lower in the female group and GRIK1 was higher in the male group (Supplementary Fig. 4).
Discussion
In the past, LC, a primary source of norepinephrine, has extensively been studied for its role in stress responsiveness28, 29. In addition, a considerable amount of attention has been paid to understand the role of LC with perspective of noradrenergic system in suicide, which suggests that dysfunction in central noradrenergic system and associated signaling may lie at the root of psychiatric disorders, including depression, that contribute to suicide18, 21. In fact, aberrant release of norepinephrine from the terminals of both afferent and efferent noradrenergic LC projections and subsequent adaptive upregulation of noradrenergic receptors has been reported in suicide subjects21, 23. These evidence demonstrate that LC may have high susceptibility to the pathological changes associated with suicide30. The present study was undertaken to further examine the role of LC specific miRNAs and associated gene regulatory networks to ascertain their molecular contribution in understanding the pathobiology of suicidal behavior.
For the first time, we not only present the evidence that the expression of miRNAs is substantially altered in LC of suicide subjects but miRNAs as well as target genes may form networks that can be crucial in underlying etiopathogenesis of suicide. We analyzed a total of 754 miRNAs, out of which, 367 miRNAs were further analyzed after normalization. We found that expression of a core group of 13 miRNAs was significantly altered in LC of suicide subjects compared with healthy control subjects. Of them 10 were upregulated (miR-17-5p, miR-20b-5p, miR-106a-5p, miR-330-3p, miR-541-3p, miR-582-5p, miR-890, miR-99b-3p, miR-550-5p, miR-1179) and 3 were downregulated (miR-409-5p, let-7g-3p, miR-1197). Construction of an integrated gene regulatory network based on predicted target genes of altered miRNAs showed a comprehensive association with neuropsychiatric disorders, which included major depression and anxiety, the two important risk factors associated with suicidal behavior. In addition, map** of cellular pathways, affected by these altered miRNAs, indicated an overall change in cellular signaling that have been implicated in suicide neurobiology. Moreover, formation of a miRNA network, which appeared to be specific to the suicide but not the control group, was noted. Altogether, our study shows that LC associated changes in miRNA expression and molecular networks may play a critical role in the pathophysiology of suicide.
Involvement of region specific neural circuits in the etiopathogenesis of depression and associated suicidal behavior is well documented31. In a previous study, we analyzed expression of miRNAs in dorsolateral prefrontal cortex (dlPFC) of suicide subjects14. Contrary to LC, we observed a global downregulation of miRNAs in this brain area of suicide subjects compared with matched healthy controls. When examined individually, we found that the expression levels of 21 miRNAs were significantly lower. In addition, 16 additional miRNAs showed a large but non-significant decrease (<35%). Interestingly, alterations in these miRNAs were associated with a set of target genes that were part of functions related to repression of chromatin structure (DNMT3B, EZH2), activation of glucocorticoid receptor (NCOA2), transcription factors (SP1, SP3, SP4 and SOX4), and apoptotic regulatory proteins (BCL2). An overall elevated expression of these target genes was predicted due to downregulated expression of targeting miRNAs in the PFC of depressed-suicide group. This is in agreement with earlier reports in pre-clinical models of depression where profound repression of PFC activity have been reported including decreased PFC volume, dendritic retraction, and spine loss32. Moreover, chromatin compaction in PFC of depressed-suicide brain has also been reported which further supports induced activity of those genes found as targets of repressed miRNAs in PFC33. In the present study, a contrasting pattern of miRNA expression was observed in the LC of depressed suicide subjects. For example, the number of miRNAs affected in LC of suicide subjects was much lower than the PFC. In addition, none of the miRNAs, which showed alterations in the PFC, except for miR-20b-5p, appeared in the list of LC-associated miRNA changes in suicide subjects. Even the expression of miR-20b-5p was upregulated in LC in contrast to PFC, where its expression was downregulated. Moreover, the elevated levels of miRNAs was found to be responsible for the dysregulation of genes associated primarily with neurotransmitter systems such as glutamate and GABA34. Altogether, our results not only suggest a complex neuroanatomical nature of LC receiving various neurochemical inputs across various brain areas35 but also indicate that suicide-associated changes in miRNAs are brain region specific and that miRNAs or associated gene networks in specific brain areas may have distinct functions in determining disease pathophysiology.
Disease pathogenesis associated with psychiatric illnesses like suicidal behavior is a highly complex molecular process which involves a diverse array of dysregulation at both genetic and epigenetic levels36, 37. In order to have a deeper insight, a system level approach needs to be perused to explain the inherent nature of changes associated with this kind of molecular dysfunctionality38. MicroRNAs, as epigenetic modifiers, are capable of regulating large sets of genes through synergism39. This synergistic interaction between sets of miRNAs stems out from their same chromosomal localization and regulation by common cellular pathways40, which allows one to build a co-relational network which could be disease specific. This is supported by our data in which we identified pairs of miRNAs that were co-regulated in their expression across individuals within a single group (control or suicide). The pairwise correlations for all miRNAs were computed within the control group as well as within the suicide group separately. We were particularly interested in identifying miRNA pairs that showed no significant correlation in the control group, yet exhibited a significant positive correlation in the suicide group and vice-versa. This phenomenon allows to detect coordinated changes as the underlying driving force for expression (e.g., due to changes in transcription factors or miRNA processing) and likely to reflect the influence of shared factor(s) which regulate miRNAs in the brain of healthy control and suicide individuals and can influence the phenotypic outcome. More interestingly, we found that separate sets of miRNAs were pairwise correlated in the LC of suicide group, which was not present in the control group. On the other hand, a separate group of co-regulated miRNAs was pairwise correlated in the control group, which was absent in the suicide group. dentification of two independently regulated synergistic networks with different sets of pairwise correlated miRNAs in control vs MDD-suicide group indicates the likely involvement of a co-regulated target gene set, bearing a suicide specific signature. Furthermore, the map** of a less intensely interacting miRNA network in the MDD-suicide group compared with control suggests a disrupted synergistic network due to maladaptive changes in underlying molecular circuitry. With a closer look of miRNA hubs in LC of suicide group, it appears that miR-129, 29a, 1243, 101 and 361 are involved exclusively in suicide phenotype and associated pathophysiology. In contrast, majority of the hubs constructing miRNAs (e.g. miR-1227, 625, 598, 590-3p, 150, 744-3p, 28, 145, 340-3p, 29c and 657) from the uniquely patterned co-expression network of control subjects did not appear to be part of any miRNA list in the suicide group. This suggests that not only is the expression of miRNAs altered, but it is reorganized in the LC of suicide subjects. We also noted that miRNAs formed a very cohesive network in the control group where miRNAs were heavily interconnected with each other within the network, but this interconnection was comparatively much less intense in the suicide group. Collectively, our data indicates a unique mode of regulation of a set of miRNAs in the MDD-suicide group, which is completely different from its counterpart in the control group and possibly leading towards a dysfunctional regulatory network with major implication in suicidal behavior. A similar phenomenon was found in our earlier rodent study, where we observed that resiliency or vulnerability to develop stress-induced behavioral depression may be linked to specific miRNA co-expression network in the frontal cortex41.
Studying chromosomal localization of miRNA clusters helps understand coordinated regulation of miRNA expression under specific pathophysiological conditions42. In this study, we observed that miRNAs, whose chromosomal localizations were in proximity (e.g., miR-20b-5p, miR-106a-5p, miR-890 on chromosome X, miR-330-3p, miR-99b-3p on chromosome 19, and miR-409-5p, miR-1197 on chromosome 14), had the same direction of changes and similar fold changes. This happened even in those miRNAs whose transcriptional units were in opposite directions (miR-330-3p and miR-99b-3p on chromosome 19). This notion signifies the evolutionary conservation pattern of gene regulation which may culminate into similar functional output43. This also has relevance with the perspective of disease pathophysiology in which LC may be regulating functional gene networks in a cohesive manner by orchestrating the coordinated transcriptional output of the altered miRNAs.
In silico prediction of target genes for the 13 altered miRNAs in the LC of suicide subjects identified many genes with a range of diverse cellular functions involved in pathways associated with neuropsychiatric disorders. Several of these genes were found to be predicted as targets of more than one miRNA from the altered list. This manifold regulation of single target gene by multiple miRNAs is a unique mechanism of miRNA-mediated gene regulation44 and can be interpreted as dynamic regulation in brain areas like LC which is known to receive a diverse set of neurochemical inputs ranging from excitatory glutamatergic to inhibitory GABAergic pathways35. In this regard, our identification of target genes such as GRIA1, GRIA3, GRIK3, GRIN2b and GAD2 linked with glutamatergic neurotransmission in LC of suicide subjects raises the possibility of miRNA-mediated dysfunctional glutamatergic system. This is further consolidated by our finding of about 80% upregulation of GRIK1 gene expression in depressed-suicide LC samples. This finding correlates well with the earlier report of impaired glutamatergic pathway in LC of depressed brain where significant up regulation was noted in the function of GRIA1, GRIK1, GRM1, and GRM5 genes in addition to genes with a functional role in presynaptic vesicular transport of glutamate (VGLUT2 or SLC17A6)45. Similar evidence has been reported in the postmortem brain studies of altered glutamatergic input to noradrenergic LC in depressed-suicide brain46. In addition to glutamatergic pathway, several target genes associated with GABAergic neurotransmission (GABARB3, GABARA4, GABARA3, GABARR1, GABARG2 and GAD2) were found in LC of suicide subjects47, which implicates a strong relationship between miRNA-mediated GABAergic deficits and LC based noradrenergic activity. Studies from postmortem brain samples of depressed subjects have also found similar impairments in GABAergic neurotransmission where altered expression of GABA receptor subtypes such as α3, γ2, β1/3, and ε have been reported48. In addition, signaling mechanisms associated with protein kinase A, phospholipase C, glucocorticoid, ERK/MAPK, neurotrophins, GSK3-β, MAO, and CRH, were also predicated to participate in LC-associated neuropathological mechanisms in suicide18, 30, 49. All these signaling components have previously been reported by us to play critical roles in mood disorders and suicide50,51,52,53,54,55,56. Interestingly, RELN gene also appeared in the predicted target list with high context score. RELN, which plays a role in regulating neural migration during brain development as well as in dendritic maturation and dendritic spine development and whose expression and function changes in depression57, was also found to be a prominent target gene in the LC of suicide subjects. We tested a few of these genes to examine whether they correlate with miRNA expression. We found that RELN, GSK-3β, and MAOA were inversely correlated with miR-1179, miR-550a-5p, miR-1197, miR-330a-3p, miR-541a-3p, miR-582-5p, suggesting that these target genes are regulated by their corresponding miRNAs.
Taken together, our present study for the first time provides evidence of a transcriptome-wide altered miRNA expression in LC of suicide subjects and characterizes associated changes in miRNA and gene regulatory networks. Our study has the limitation that the number of subjects is low in both control and suicide groups; however, we were highly selective in choosing the samples that were very well characterized, had no known neuropathology, and were devoid of confounding variables such as substance abuse, alcohol or antidepressants treatment. Even with these low sample numbers, the results appear to be quite robust where we could identify significant gene and miRNA networks associated with suicidal behavior. The study in suicide subjects was conducted in the context of depression, which suggests that miRNA and gene networks in depressed individuals may be critical in the development of suicidal behavior. To further understand whether this is a general phenomenon of suicide, it will be required to further dissect our findings from depression to suicide which will require addition of suicide cases with other psychiatric disorders.
In conclusion, our present study substantially contributes to our understanding of how miRNAs and gene networks are reorganized in LC of suicide subjects and serves as a foundation to further explore more mechanistic studies. One example would be to conduct promoter-wide miRNA methylome study to find out the possible regulatory mechanism behind the altered transcription of miRNAs.
Methods
Subjects and postmortem tissue
The study was performed in locus coeruleus (LC) obtained from 10 non-psychiatric controls (referred as normal controls) and 9 depressed suicide subjects. Family members signed written informed consents and the study was approved by the Institutional Review Board of the University of Alabama at Birmingham and all methods were performed in accordance with the relevant guidelines and regulations. Brain tissues were collected according to the Lenhossek Human Brain Program, in the Human Brain Tissue Bank, Semmelweis University, Budapest, Hungary. The major advantage of using samples from this brain bank is that postmortem interval (PMI) is very short and RNA integrity numbers of the tissues are excellent. Psychiatric diagnoses of the subjects were made by means of the psychological autopsy method using DSM-IV58. The demographic and clinical characteristics of the subjects are provided in Table 1. Examination of medical records of controls subjects showed the absence of a history of psychiatric illnesses. Causes of death in control subjects were acute cardiac failure or myocardial infarction. All suicide subjects had a diagnosis of major depression and died by hanging or jum** from height. All subjects died suddenly and had a very short agonal state. Toxicology and presence of antidepressants were examined in blood samples obtained from these subjects. None of the subjects had positive antidepressant toxicology or substance abuse or alcohol. Suicide subjects included in the study were not taking antidepressants at least 2 month prior to death.
LC was dissected using the following procedure: after removal from the skull, the brains were cut in six major pieces (four cortical lobes, basal ganglia-diencephalon and lower brain stem-cerebellum), rapidly frozen on dry ice, and stored at −70 °C until dissection. At the time of the dissection the brain samples were sliced into 1–1.5 mm thick coronal sections at a temperature of 0–10 °C. The LC was recognized on two sequent sections in the rostral part of the pontine tegmentum, at the two sides of the fourth ventricle. Special microdissection needles53, 54 with 1.0 mm inside diameter were used to collect 4 tissue pellets containing LC. None of the control and suicide subjects showed evidence of abnormal neuropathology.
RNA isolation
Total RNA was isolated from LC using a modified protocol41 designed to optimize recovery of small RNAs. Glycoblue 20 μg (Ambion, Waltham, MA, USA) was added to the RNA precipitation step, which was allowed to proceed overnight at −20 °C. The RNA pellet was spun down at 20,000 × g for 25 min at 4 °C; rinsed with 80% ethanol in nuclease-free water; resuspended in RNAsecure (Ambion, Waltham, MA, USA); and treated with DNase I using DNA-free kit (Ambion, Waltham, MA, USA). The purity and integrity of RNAs were determined by measuring the optical density with an absorbance ratio of 260/280 (NanoDrop spectrophotometer, ThermoScientific, Waltham, MA, USA) and running the samples on agarose gel. RNA integrity numbers were also determined in all samples.
TLDA-based miRNA expression analysis
Expression of miRNAs was determined as described earlier13. Reverse transcription (RT) was performed following the manufacturer’s protocol with the TaqMan MiRNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA) and the multiplex RT for TaqMan MicroRNA Assays that consisted of eight predefined RT primer pools. For each RT pool, 100 ng of total RNA was used and the product was diluted 1:62.5 and 55 μl diluted product mixed with 55 μl of TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA, USA), no AmpErase® UNG. One hundred microliter of each mix was dispensed in the appropriate well in the TaqMan Human MicroRNA Array v3.0 (Taqman low density array (TLDA), Applied Biosystems) and run for 40 cycles on an ABI 7900HT RT-PCR machine (Applied Biosystems). miRNAs were assayed on two plates, A and B; A plates contained many of the canonical miRNA sequences in miRBase, whereas the B plate primarily contained minor or star (*) miRNA sequences arising from the opposite arm of the pre-miR hairpin precursor. A sample processed without RT showed no detectable miRNA values. Using samples run on duplicate plates to monitor inter-plate reliability, we observed that Ct values > 35 were less reliable, so Ct ≤ 35 was set as the threshold of detectability. Median values (miRNAs and small RNAs) of each replicate was determined and used for normalization. We also checked geometric means of endogenous genes provided within the TLDA plates (U6, RNU44 and RNU48). The geometric means of these endogenous RNAs, which is represented as Ct values, did not change between healthy controls and suicide subjects (Plate A: Control: 22.55 ± 0.68; Suicide: 21.49 ± 0.51, Plate B: Control: 22.38 ± 0.88; Suicide: 22.40 ± 0.65). Plant-specific ath-miR-159a was included in the TLDA plate as negative control, which did not show any expression in human LC derived RNA. Fold-differences in miRNA expression across groups were calculated following ΔΔCt method as described earlier59. Based on median normalization, dCt values were determined for each miRNA and hierarchical clustering was performed to create a gene expression heat map using ClustVis (BETA) software60.
Target genes and network analysis
Statistically significant miRNAs were analyzed for their mRNA targets using Ingenuity Pathway Analysis Software (IPA; Qiagen, Valencia, CA, USA). Briefly, the miRNA-target modules in IPA were used to filter a list of significantly altered up or downregulated miRNAs to retrieve a population of target mRNAs. Two sets of target mRNAs were analyzed. In one, mRNA target gene set was prepared using TarBase, Ingenuity Expert Finding and miRecords (Qiagen, Redwood City, CA, USA) with experimental validation. In another, mRNA target gene set was prepared based on number of conserved targeting site and total context score prediction value with a high-to-moderate degree of 3ʹ untranslated region-binding specificity with the miRNA seed sequence using TargetScan (Cambridge, MA, USA). The short-listed target genes were further analyzed with IPA core analysis module for functional enrichment of target genes deciphering their role in canonical pathways, molecular networks, and disease pathways using Fisher Exact Test. P-value threshold was set at ≤ 0.05. The initial data output from canonical pathway was filtered by setting the criteria stringently to represent only a few selected pathways related to stress and psychiatric disorders. Further analysis on predicted and validated target genes of differentially expressed miRNAs were carried out using mirPath (version 3) from DIANA Tools61 and CyTargetLinker plugin from Cytoscape software (version 3.0). The purpose of these advanced analyses was to find out affected pathways in relation to pathophysiological state and linking with the gene ontology (GO) of the target genes based on their molecular functions.
Co-expression analysis
To identify pairs of miRNAs significantly correlated in the suicide group, but not in the control groups, we conducted co-expression analysis. In this analysis, miRNAs were first filtered to include only those who showed Ct values ≤ 35 in the two groups. The Ct values for each miRNAs were normalized to the global mean Ct value of the individual sample to exclude the false positive correlations caused by differences among individuals in overall miRNA content. Next, all miRNAs were detected pairwise and the Pearson correlation coefficient was determined for each group (control and suicide) separately. Note that for n = 9 for suicide and n = 11 for control subjects, only correlations of r = 0.7 or greater were significantly different from 0 at p = 0.05. Finally, we selected pairs of miRNAs that met the following criteria: 1) they demonstrated a significant positive correlation in the suicide group (r-suicide > 0.7); 2) the pairs did not exhibit a significant negative correlation in the control group (0.7 > r-control > −0.7); 3) correlation coefficients in the suicide group were higher than in the control group (r-suicide minus r-control > 0.8). A similar analysis was conducted in the control group to identify pairwise correlation in the control but not in the suicide group. We utilized the igraph package in R62 to display pairwise co-expression relationships with networks where nodes represented miRNAs and edges represented connected pairs of miRNAs.
Expression analysis of select target genes by qPCR
To examine whether altered miRNAs were associated with changes in the expression of predicted target genes, we randomly selected six genes that show putative binding sites for certain significantly altered miRNAs and have relevance in depression and anxiety related pathophysiology. mRNA levels of these genes were determined by qPCR using EvaGreen/SybrGreen-based reaction chemistry (EvaGreen qPCR Mastermix, Applied Biological Materials, Richmond, Canada) as discussed above. The primer sequences are listed in Supplementary Table 1. Human specific GAPDH primer was used as endogenous control. The results were calculated using ΔΔCt method and reported as fold change.
Statistical analysis
A total of 754 miRNAs were measured in TLDA plate; however, after excluding miRNAs with Ct value > 35, a total of 355 miRNAs were further analyzed. The non-parametric Wilcoxon sign-rank test, 2-tailed was utilized when making lists of miRNAs whose mean expression levels differed significantly across the two groups (control and suicide), since this test is appropriate for miRNAs whether or not they follow a normal distribution63. The Bonferroni correction of statistical significance values was not appropriate in this study because it assumes that the expression of the vast majority of genes is independent of each other. This situation does not apply in the case of miRNAs, which form extensive cross-correlation networks –in some cases due to co-transcription from the same primary gene transcripts64, 65. Instead, we performed SAM analysis (Significance Analysis of Microarrays software, version 3.08, Stanford University, http://www-stat.stanford.edu/~tibs/SAM/), which estimated statistical significance by subjecting the data to multiple random permutations; parameters were set for two-class unpaired analysis, Wilcoxon statistic and 5000 permutations14, 66. The correlation between miRNAs and various genes with PMI, age, and brain pH, were determined by Pearson product-moment correlation analysis. An α level ≤ 0.05 was considered significant.
Data availability statement
All data generated or analyzed during this study are included in this published article (and its Supplementary Information files).
References
Murray, C. J. & Lopez, A. D. Evidence-based health policy–lessons from the Global Burden of Disease Study. Science 274, 740–743 (1996).
Kessler, R. C. et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama 289, 3095–3105, doi:10.1001/jama.289.23.3095 (2003).
Sequeira, A. et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Molecular psychiatry 12, 640–655, doi:10.1038/sj.mp.4001969 (2007).
Bagot, R. C., Labonte, B., Pena, C. J. & Nestler, E. J. Epigenetic signaling in psychiatric disorders: stress and depression. Dialogues in clinical neuroscience 16, 281–295 (2014).
Roy, B. & Dwivedi, Y. Understanding epigenetic architecture of suicide neurobiology: A critical perspective. Neuroscience and biobehavioral reviews 72, 10–27, doi:10.1016/j.neubiorev.2016.10.031 (2016).
Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
Kozomara, A. & Griffiths-Jones, S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic acids research 42, D68–73, doi:10.1093/nar/gkt1181 (2014).
Gosline, S. J. et al. Elucidating MicroRNA Regulatory Networks Using Transcriptional, Post-transcriptional, and Histone Modification Measurements. Cell reports 14, 310–319, doi:10.1016/j.celrep.2015.12.031 (2016).
Chen, X., Liang, H., Zhang, C. Y. & Zen, K. miRNA regulates noncoding RNA: a noncanonical function model. Trends in biochemical sciences 37, 457–459, doi:10.1016/j.tibs.2012.08.005 (2012).
Kloosterman, W. P. & Plasterk, R. H. The diverse functions of microRNAs in animal development and disease. Developmental cell 11, 441–450, doi:10.1016/j.devcel.2006.09.009 (2006).
Dwivedi, Y. Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications. Dialogues in clinical neuroscience 16, 43–61 (2014).
Im, H. I. & Kenny, P. J. MicroRNAs in neuronal function and dysfunction. Trends in neurosciences 35, 325–334, doi:10.1016/j.tins.2012.01.004 (2012).
Dwivedi, Y. et al. Chronic corticosterone-mediated dysregulation of microRNA network in prefrontal cortex of rats: relevance to depression pathophysiology. Translational psychiatry 5, e682, doi:10.1038/tp.2015.175 (2015).
Smalheiser, N. R. et al. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One 7, e33201, doi:10.1371/journal.pone.0033201 (2012).
Berridge, C. W. & Waterhouse, B. D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain research. Brain research reviews 42, 33–84 (2003).
George, S. A. et al. Altered locus coeruleus-norepinephrine function following single prolonged stress. The European journal of neuroscience 37, 901–909, doi:10.1111/ejn.12095 (2013).
Ziegler, D. R., Cass, W. A. & Herman, J. P. Excitatory influence of the locus coeruleus in hypothalamic-pituitary-adrenocortical axis responses to stress. Journal of neuroendocrinology 11, 361–369 (1999).
Dwivedi, Y. The Neurobiological Basis of Suicide. (CRC Press, 2012).
Gonzalez-Maeso, J., Rodriguez-Puertas, R., Meana, J. J., Garcia-Sevilla, J. A. & Guimon, J. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors. Molecular psychiatry 7, 755–767, doi:10.1038/sj.mp.4001067 (2002).
Valdizan, E. M. et al. alpha(2)-Adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biological psychiatry 68, 869–872, doi:10.1016/j.biopsych.2010.07.023 (2010).
Ordway, G. A., Widdowson, P. S., Smith, K. S. & Halaris, A. Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. Journal of neurochemistry 63, 617–624 (1994).
Zhu, H. et al. Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicide. Brain research 1125, 138–146, doi:10.1016/j.brainres.2006.09.082 (2006).
Zhu, M. Y. et al. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biological psychiatry 46, 1275–1286 (1999).
Schroeder, A. et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC molecular biology 7, 3, doi:10.1186/1471-2199-7-3 (2006).
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic acids research 45, D353–d361, doi:10.1093/nar/gkw1092 (2017).
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic acids research 44, D457–462, doi:10.1093/nar/gkv1070 (2016).
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research 28, 27–30 (2000).
Foote, S. L., Bloom, F. E. & Aston-Jones, G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiological reviews 63, 844–914 (1983).
Bremner, J. D., Krystal, J. H., Southwick, S. M. & Charney, D. S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (New York, N.Y.) 23, 28–38, doi:10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J (1996).
Ordway, G. A. Pathophysiology of the locus coeruleus in suicide. Annals of the New York Academy of Sciences 836, 233–252 (1997).
van Heeringen, K., Bijttebier, S., Desmyter, S., Vervaet, M. & Baeken, C. Is there a neuroanatomical basis of the vulnerability to suicidal behavior? A coordinate-based meta-analysis of structural and functional MRI studies. Frontiers in human neuroscience 8, 824, doi:10.3389/fnhum.2014.00824 (2014).
Sun, H., Kennedy, P. J. & Nestler, E. J. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 38, 124–137, doi:10.1038/npp.2012.73 (2013).
Nagy, C., Torres-Platas, S. G., Mechawar, N. & Turecki, G. Repression of Astrocytic Connexins in Cortical and Subcortical Brain Regions and Prefrontal Enrichment of H3K9me3 in Depression and Suicide. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). doi:10.1093/ijnp/pyw071 (2016).
Chandley, M. J. & Ordway, G. A. In The Neurobiological Basis of Suicide (ed Y. Dwivedi) (CRC Press/Taylor & Francis Llc., 2012).
Samuels, E. R. & Szabadi, E. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Current neuropharmacology 6, 235–253, doi:10.2174/157015908785777229 (2008).
Fu, Q. et al. A twin study of genetic and environmental influences on suicidality in men. Psychological medicine 32, 11–24 (2002).
Turecki, G. Epigenetics and suicidal behavior research pathways. American journal of preventive medicine 47, S144–151, doi:10.1016/j.amepre.2014.06.011 (2014).
Tretter, F. & Albus, M. Systems biology and psychiatry - modeling molecular and cellular networks of mental disorders. Pharmacopsychiatry 41(Suppl 1), S2–s18, doi:10.1055/s-2008-1081461 (2008).
Zhang, J., Duy, L. T., Liu, L., He, J. & Li, J. Identifying miRNA synergistic regulatory networks in heterogeneous human data via network motifs. Molecular bioSystems 12, 454–463, doi:10.1039/c5mb00562k (2016).
Xu, J. et al. MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features. Nucleic acids research 39, 825–836, doi:10.1093/nar/gkq832 (2011).
Smalheiser, N. R. et al. MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 14, 1315–1325, doi:10.1017/s1461145710001628 (2011).
Altuvia, Y. et al. Clustering and conservation patterns of human microRNAs. Nucleic acids research 33, 2697–2706, doi:10.1093/nar/gki567 (2005).
Grinchuk, O. V., Jenjaroenpun, P., Orlov, Y. L., Zhou, J. & Kuznetsov, V. A. Integrative analysis of the human cis-antisense gene pairs, miRNAs and their transcription regulation patterns. Nucleic acids research 38, 534–547, doi:10.1093/nar/gkp954 (2010).
Pasquinelli, A. E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nature reviews. Genetics 13, 271–282, doi:10.1038/nrg3162 (2012).
Bernard, R. et al. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Molecular psychiatry 16, 634–646, doi:10.1038/mp.2010.44 (2011).
Chandley, M. J. et al. Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 17, 1569–1578, doi:10.1017/s1461145714000662 (2014).
Poulter, M. O. et al. Altered Organization of GABA(A) Receptor mRNA Expression in the Depressed Suicide Brain. Frontiers in molecular neuroscience 3, 3, doi:10.3389/neuro.02.003.2010 (2010).
Brambilla, P., Perez, J., Barale, F., Schettini, G. & Soares, J. C. GABAergic dysfunction in mood disorders. Molecular psychiatry 8, 721–737, doi:10.1038/sj.mp.4001362 (2003). 715.
Oquendo, M. A. et al. Toward a biosignature for suicide. The American journal of psychiatry 171, 1259–1277, doi:10.1176/appi.ajp.2014.14020194 (2014).
Ren, X., Rizavi, H. S., Khan, M. A., Dwivedi, Y. & Pandey, G. N. Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3beta and beta-catenin. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 16, 945–955, doi:10.1017/s1461145712001010 (2013).
Pandey, G. N., Ren, X., Rizavi, H. S. & Dwivedi, Y. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment. Journal of psychiatric research 44, 143–148, doi:10.1016/j.jpsychires.2009.07.009 (2010).
Dwivedi, Y. et al. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1). The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 12, 1337–1354, doi:10.1017/s1461145709990575 (2009).
Dwivedi, Y., Rizavi, H. S., Conley, R. R. & Pandey, G. N. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Molecular psychiatry 11, 86–98, doi:10.1038/sj.mp.4001744 (2006).
Dwivedi, Y. et al. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. Journal of neurochemistry 77, 916–928 (2001).
Dwivedi, Y. et al. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biological psychiatry 55, 234–243 (2004).
Pandey, G. N. et al. Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects. The American journal of psychiatry 156, 1895–1901, doi:10.1176/ajp.156.12.1895 (1999).
Caruncho, H. J. et al. Reelin-Related Disturbances in Depression: Implications for Translational Studies. Frontiers in cellular neuroscience 10, 48, doi:10.3389/fncel.2016.00048 (2016).
First, M. B. Diagnostic and statistical manual of mental disorders. DSM IV-4th edition. APA, 1994 (1994).
Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25, 402–408, doi:10.1006/meth.2001.1262 (2001).
Metsalu, T. & Vilo, J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic acids research 43, W566–570, doi:10.1093/nar/gkv468 (2015).
Vlachos, I. S. et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic acids research 43, W460–466, doi:10.1093/nar/gkv403 (2015).
Csárdi G., N. T. The igraph software package for complex network research. Inter. J. Comp. Syst. 1695 (2006).
Hardin, J. & Wilson, J. A note on oligonucleotide expression values not being normally distributed. Biostatistics (Oxford, England) 10, 446–450, doi:10.1093/biostatistics/kxp003 (2009).
Lugli, G., Torvik, V. I., Larson, J. & Smalheiser, N. R. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. Journal of neurochemistry 106, 650–661, doi:10.1111/j.1471-4159.2008.05413.x (2008).
Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401–1414, doi:10.1016/j.cell.2007.04.040 (2007).
Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98, 5116–5121, doi:10.1073/pnas.091062498 (2001).
Acknowledgements
The research was partly supported by grants from National Institute of Mental Health (R01MH082802; R21MH081099; 1R01MH101890; R01MH100616; 1R01MH107183-01), American Foundation for Suicide Prevention (SRG-XXXX-001778-1209) to Dr. Dwivedi and KTIA_NAP_13-1-2013-0001 to Dr. Palkovits.
Author information
Authors and Affiliations
Contributions
B.R. conducted the experiments, analyzed the data, and wrote the manuscript; Q.W. conducted bioinformatics analyses and wrote the manuscript; M.P. and G.F. collected and dissected brain areas and provided the psychological autopsy, demographic, and clinical data and participated in writing the discussion; Y.D. designed the experiments and wrote the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Roy, B., Wang, Q., Palkovits, M. et al. Altered miRNA expression network in locus coeruleus of depressed suicide subjects. Sci Rep 7, 4387 (2017). https://doi.org/10.1038/s41598-017-04300-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-04300-9
- Springer Nature Limited
This article is cited by
-
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Signal Transduction and Targeted Therapy (2024)
-
Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential
Signal Transduction and Targeted Therapy (2023)
-
Temporal effects on death by suicide: empirical evidence and possible molecular correlates
Discover Mental Health (2023)
-
Alterations in microRNA of extracellular vesicles associated with major depression, attention-deficit/hyperactivity and anxiety disorders in adolescents
Translational Psychiatry (2023)
-
Identification of transcriptome alterations in the prefrontal cortex, hippocampus, amygdala and hippocampus of suicide victims
Scientific Reports (2021)